KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Assets Average (2016 - 2025)

Historic Assets Average for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $29.3 billion.

  • Biogen's Assets Average rose 405.32% to $29.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $29.3 billion, marking a year-over-year increase of 405.32%. This contributed to the annual value of $28.7 billion for FY2025, which is 472.67% up from last year.
  • Biogen's Assets Average amounted to $29.3 billion in Q4 2025, which was up 405.32% from $28.8 billion recorded in Q3 2025.
  • In the past 5 years, Biogen's Assets Average registered a high of $29.3 billion during Q4 2025, and its lowest value of $23.7 billion during Q1 2022.
  • Over the past 5 years, Biogen's median Assets Average value was $25.8 billion (recorded in 2022), while the average stood at $26.1 billion.
  • In the last 5 years, Biogen's Assets Average plummeted by 914.64% in 2021 and then skyrocketed by 1139.42% in 2023.
  • Biogen's Assets Average (Quarter) stood at $23.8 billion in 2021, then rose by 3.62% to $24.7 billion in 2022, then grew by 11.39% to $27.5 billion in 2023, then increased by 2.41% to $28.2 billion in 2024, then increased by 4.05% to $29.3 billion in 2025.
  • Its Assets Average stands at $29.3 billion for Q4 2025, versus $28.8 billion for Q3 2025 and $28.2 billion for Q2 2025.